Table 1

Table.  Drugs for Pancreatic Cancer

 

 

Product

 

Class

 

Target

 

Clinical Stage

 

Manufacturer

 

 

ABX-EGF

 

Antibody

 

EGFR

 

Phase I

Amgen and Abgenix

 

G17DT

 

Hormone

 

G-17

 

Phase II

Aphton and Aventis

 

Avicine

 

Vaccine

 

hCG

 

Phase III

 

AVI Biopharma

 

ISIS2503

 

Antisense

 

Ha-ras

 

Phase II

Isis Pharmaceuticals

 

ISIS112989

 

Antisense

Secretory protein clusterin

 

Phase II

Isis Pharmaceuticals

 

Perifosine

 

Kinase inhibitor

AKT/protein kinase B

 

Phase II

 

Aetera Zentaris

 

Tarceva

 

Small molecule

 

EGFR

 

Phase III

Genentech

and OSI

 

Taxotere

 

Tubulin inhibitor

 

Microtubulin

 

Phase I

 

Aventis